Skytrofa (lonapegsomatropin or lonapegsomatropin-tcgd) is a prescription growth hormone therapy used to treat children 1 year and older with low growth hormone levels. It's given as a weekly injection under the skin using an autoinjector, which can be done at home. Common side effects include viral infection, fever, cough, nausea, and vomiting.
Skytrofa (lonapegsomatropin) is a growth hormone analog. It works just like the growth hormone (GH) the body naturally makes. By acting like growth hormone, Skytrofa (lonapegsomatropin) starts a series of steps in the body that help your child grow.
The following side effects may get better over time as your body gets used to the medication. Let your healthcare provider know immediately if you continue to experience these symptoms or if they worsen over time.
Contact your healthcare provider immediately if you experience any of the following.
Side effects that you should report to your care team as soon as possible:
Side effects that usually do not require medical attention (report these to your care team if they continue or are bothersome):
How to inject Skytrofa (lonapegsomatropin) at home:
Your child's endocrinologist will decide when it's safe to start Skytrofa (lonapegsomatropin) after an appendectomy. In general, Skytrofa (lonapegsomatropin) isn't recommended for children who are ill from complications after certain surgeries, including stomach-related surgeries like an appendectomy. After your child has fully recovered, their prescriber will decide when it's safe to begin treatment.
In studies, children taking Skytrofa (lonapegsomatropin) grew about 11 cm in height over one year. Your child's prescriber will monitor their growth to make sure this medication is working well for them.
No, Skytrofa (lonapegsomatropin) isn't considered a controlled substance by the Drug Enforcement Administration (DEA). But medications like Skytrofa (lonapegsomatropin) that promote growth can sometimes be used illegally for athletic performance, bodybuilding, or reducing body fat. Always use Skytrofa (lonapegsomatropin) exactly as prescribed for your child. Be sure to keep it in a secure place away from others who shouldn’t have access to it.
Store Skytrofa (lonapegsomatropin) cartridges in the refrigerator in the original carton to protect them from light. Alternatively, you can keep them at room temperature for up to 6 months. If you take the medication out of the refrigerator, you can put it back, but it will still expire 6 months from the date it was first removed.
Both Skytrofa (lonapegsomatropin) and somatropin, brand names like Omnitrope and Norditropin are used to treat low growth hormone levels in children. While Omnitrope and Norditropin are also approved for use in adults, Skytrofa (lonapegsomatropin) has only been studied in children. A key difference is that Skytrofa (lonapegsomatropin) is a longer-acting form of somatropin, meaning it only needs to be injected once a week, compared to the almost daily injections required for Omnitrope and other somatropin brand names. Speak to your child's endocrinologist if you have questions about comparing these medications.
Skytrofa (lonapegsomatropin) can cause some serious health issues. This risk may be even higher for certain groups. If this worries you, talk to your doctor or pharmacist about other options.
There have been reports of a growth hormone medication similar to Skytrofa (lonapegsomatropin) raising the risk of death when used in people with a critical illness from open heart or stomach surgery, serious injuries, or a severe breathing problem. Let your child's prescriber know right away if they develop any serious health problems while taking this medication.
Severe allergic reactions to Skytrofa (lonapegsomatropin) are rare but possible. These reactions include life-threatening reactions like anaphylaxis (closing of the throat). If you notice your child experiencing dizziness, a choking sensation, nausea, swelling around the eyes, swelling of the lips or tongue, or difficulty breathing after using Skytrofa (lonapegsomatropin), get medical attention right away.
Skytrofa (lonapegsomatropin) shouldn't be used in children with an active tumor or cancer. Let your child's prescriber know if your child has a history of any type of cancer. Growth hormone replacement products like Skytrofa (lonapegsomatropin) have been shown to raise the risk of cancer. Your child's prescriber will monitor your child during and after treatment with Skytrofa (lonapegsomatropin) and will stop treatment at the first sign of potential cancer development. Let them know right away if you notice changes in your child’s behavior, new or worsening headaches, vision problems, changes in skin color, or changes in the size or shape of existing moles.
Skytrofa (lonapegsomatropin) can make the body less sensitive to insulin, the hormone that helps lower blood sugar. This can lead to high blood sugar and raise your child's risk of diabetes. Your child's prescriber might ask you to monitor their blood sugar level while they're taking Skytrofa (lonapegsomatropin). Be aware of symptoms of high blood sugar, such as feeling very thirsty, needing to urinate often, and feeling very tired. Contact your child's prescriber if you notice any of these.
Rarely, a medication similar to Skytrofa (lonapegsomatropin) has caused high blood pressure in the blood vessels in the brain, known as intracranial hypertension. This condition can lead to vision changes and symptoms like headache, nausea, and vomiting. Symptoms typically occur within 2 months of starting treatment. Your child's prescriber will likely perform routine exams before and during treatment with Skytrofa (lonapegsomatropin) to check for this condition.
It's possible for Skytrofa (lonapegsomatropin) to cause a build-up of fluid in the body. This can lead to symptoms like swelling (edema), joint pain, muscle pain, and nerve compression problems like carpal tunnel syndrome. Contact your child's prescriber if you notice any swelling in the arms and legs, shortness of breath, or weight gain in a short amount of time.
Skytrofa (lonapegsomatropin) can lower levels of cortisol, a natural hormone that's involved in many processes, such as controlling blood sugar, blood pressure, and inflammation. Let your prescriber know if you experience symptoms of low cortisol, such as feeling weak, tired, dizzy, losing your appetite, or noticing mood changes.
Skytrofa (lonapegsomatropin) can also lower your thyroid hormone levels, which can prevent the medication from working well. Your prescriber will likely perform routine tests to make sure hormone levels are healthy and adjust the dose if needed.
Since Skytrofa (lonapegsomatropin) stimulates growth in children, it can sometimes cause a hip problem called slipped capital femoral epiphysis, where the thigh bone slips out of the socket. This problem is more common in children who start to grow quickly. Contact your child's prescriber if they have a limp or complains of hip or knee pain during treatment.
If your child has scoliosis, taking Skytrofa (lonapegsomatropin) could make it worse because of their faster growth. But the medication itself doesn't cause this condition. Your child's prescriber will check them regularly for worsening symptoms of scoliosis, such as an uneven waist or shoulders or if their body leans to one side.
Rarely, another medication like Skytrofa (lonapegsomatropin) has been linked to pancreatitis, which is inflammation of the pancreas. Children taking Skytrofa (lonapegsomatropin) might have a higher risk than adults. Contact your child's prescriber if they complain of sudden, severe stomach pain.
Skytrofa (lonapegsomatropin) shouldn't be used in children with growth problems due to a genetic condition called Prader-Willi syndrome. This is because deaths have been reported in children with this condition who were treated with a similar medication and had risk factors like obesity or sleep apnea.
| Dosage | Quantity | Price as low as | Price per unit |
|---|---|---|---|
| 11mg | 1 carton | $11,224.43 | $11,224.43 |
| 13.3mg | 1 carton | $13,570.06 | $13,570.06 |
| 0.7mg | 1 carton | $3,065.75 | $3,065.75 |
| 1.4mg | 1 carton | $3,065.75 | $3,065.75 |
| 1.8mg | 1 carton | $3,065.75 | $3,065.75 |
| 2.1mg | 1 carton | $3,065.75 | $3,065.75 |
| 2.5mg | 1 carton | $3,065.75 | $3,065.75 |
The dose of Skytrofa (lonapegsomatropin) is based on your child's weight.
The typical dose is 0.24 mg/kg injected under the skin once a week.
Contraindications are specific health conditions or situations in which a person should not take a medication due to safety concerns. If you have any of the following conditions or if any of the following apply to you, let your healthcare provider know because Skytrofa (lonapegsomatropin) will not be safe for you to take.